Study: NCT05603195

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN7508 (IV)
Description: Administered sequential, ascending single intravenous (IV) dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN7508 (IV)
Description: Administered sequential, ascending single intravenous (IV) dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN7508 (IV)
Description: Administered sequential, ascending single intravenous (IV) dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN7508 (IV)
Description: Administered sequential, ascending single intravenous (IV) dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN7508 (IV)
Description: Administered sequential, ascending single intravenous (IV) dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN7508 (SC)
Description: Administered sequential, ascending single subcutaneous (SC) dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN7508 (SC)
Description: Administered sequential, ascending single subcutaneous (SC) dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN7508 (SC)
Description: Administered sequential, ascending single subcutaneous (SC) dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN7508 (SC)
Description: Administered sequential, ascending single subcutaneous (SC) dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: REGN7508 (SC)
Description: Administered sequential, ascending single subcutaneous (SC) dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo (IV)
Description: Administered sequential, ascending single intravenous (IV) dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo (IV)
Description: Administered sequential, ascending single intravenous (IV) dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo (IV)
Description: Administered sequential, ascending single intravenous (IV) dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo (IV)
Description: Administered sequential, ascending single intravenous (IV) dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo (IV)
Description: Administered sequential, ascending single intravenous (IV) dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo (IV)
Description: Administered sequential, ascending single intravenous (IV) dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo (SC)
Description: Administered sequential, ascending single subcutaneous (SC) dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo (SC)
Description: Administered sequential, ascending single subcutaneous (SC) dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo (SC)
Description: Administered sequential, ascending single subcutaneous (SC) dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo (SC)
Description: Administered sequential, ascending single subcutaneous (SC) dose

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Matching Placebo (SC)
Description: Administered sequential, ascending single subcutaneous (SC) dose